Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference37 articles.
1. Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
2. AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
3. Modes of resistance to anti-angiogenic therapy
4. Hypoxia and cancer
5. Challenges and Pitfalls of Combining Targeted Agents in Phase I Studies
Cited by 333 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Halofuginone-guided nano-local therapy: Nano-thermosensitive hydrogels for postoperative metastatic canine mammary carcinoma with scar removal;International Journal of Pharmaceutics: X;2024-06
2. LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer;Cell Death & Disease;2024-05-03
3. Overexpression of YAP confers radioresistance to esophageal cancer by altering the tumor microenvironment;Environmental Toxicology;2024-02-20
4. Associations between HIFs and tumor immune checkpoints: mechanism and therapy;Discover Oncology;2024-01-02
5. Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions;Cellular Signalling;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3